Dynamics of SARS-CoV-2 seroprevalence during the first year of the COVID-19 pandemic in the Northeast region of Brazil

被引:1
作者
de Souza Araujo, Adriano Antunes [1 ,2 ,3 ]
Quintans-Junior, Lucindo Jose [2 ,3 ,4 ]
Heimfarth, Luana [2 ]
Schimieguel, Dulce Marta [1 ,3 ]
Correa, Cristiane Bani [2 ,5 ]
de Moura, Tatiana Rodrigues [2 ,5 ]
Marques Cavalcante, Rafael Ciro [6 ]
Grespan, Renata [4 ,7 ]
Siqueira Quintans, Jullyana de Souza [2 ,4 ]
dos Santos, Danillo Menezes [2 ]
da Silva, Danilo Nobre [2 ]
Matos de Oliveira, Yrna Lorena [2 ]
Farias de Franca, Mariana Nobre [2 ]
Silva, Marcilio da Conceicao [6 ]
Freitas de Sa, Darla Lorena [3 ]
de Carvalho, Fernanda Oliveira [2 ]
de Souza, Mercia Feitosa [8 ]
de Oliveira Goes, Marco Aurelio [8 ,9 ]
Santos, Victor Santana [2 ,9 ]
Martins-Filho, Paulo Ricardo [2 ,10 ]
机构
[1] Univ Fed Sergipe, Dept Pharm, Sao Cristovao, Sergipe, Brazil
[2] Univ Fed Sergipe, Hlth Sci Grad Program, Aracaju, Sergipe, Brazil
[3] Univ Fed Sergipe, Grad Program Pharmaceut Sci, Sao Cristovao, Sergipe, Brazil
[4] Univ Fed Sergipe, Dept Physiol, Sao Cristovao, Sergipe, Brazil
[5] Univ Fed Sergipe, Dept Morphol, Sao Cristovao, Sergipe, Brazil
[6] Univ Fed Sergipe, Dept Pharm, Lagarto, Sergipe, Brazil
[7] Univ Fed Sergipe, Grad Program Physiol Sci, Sao Cristovao, Sergipe, Brazil
[8] Govt Sergipe State, State Hlth Dept, Aracaju, Sergipe, Brazil
[9] Univ Fed Sergipe, Dept Med, Lagarto, Sergipe, Brazil
[10] Univ Fed Sergipe, Invest Pathol Lab, Aracaju, Sergipe, Brazil
关键词
COVID-19; SARS-CoV-2; Seroepidemiologic studies;
D O I
10.1080/20477724.2022.2121366
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
In this household-based seroepidemiological survey, we analyzed the dynamics of SARS-CoV-2 seroprevalence during the first year of the COVID-19 pandemic in Sergipe State, Northeast Brazil, the poorest region of the country. A total of 16,547 individuals were tested using a rapid IgM-IgG antibody test and fluorescence immunoassay (FIA). Seroprevalence rates were presented according to age, sex, and geographic region. A comparative analysis was performed between the results obtained in July 2020 (peak of the first wave), August - November 2020 (end of the first wave), and February - March 2021 (beginning of the second wave). Seroprevalence rates in the three phases were estimated at 9.3% (95% CI 8.5-10.1), 12.0% (95% CI 11.2-12.9) and 15.4% (95% CI 14.5-16.4). At the end of the first wave, there was a rise in seroprevalence in the countryside (p < 0.001). At the beginning of the second wave, we found an increase in seroprevalence among women (p < 0.001), adults aged 20 to 59 years (p < 0.001), and the elderly (p < 0.001). In this phase, we found an increase in estimates both in metropolitan areas and in the countryside (p < 0.001). This study showed an increase in SARS-CoV-2 seroprevalence over the first year of the pandemic, with approximately one in six people having anti-SARS-CoV-2 antibodies at the beginning of the second wave of COVID-19. Furthermore, our results suggest a rapid spread of COVID-19 from metropolitan areas to the countryside during the first months of the pandemic.
引用
收藏
页码:505 / 512
页数:8
相关论文
共 20 条
  • [1] The Power of Antibody-Based Surveillance
    Alter, Galit
    Seder, Robert
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (18) : 1782 - 1784
  • [2] Ayoub Houssein H, 2021, Glob Epidemiol, V3, P100068, DOI 10.1016/j.gloepi.2021.100068
  • [3] Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020
    Bajema, Kristina L.
    Wiegand, Ryan E.
    Cuffe, Kendra
    Patel, Sadhna V.
    Iachan, Ronaldo
    Lim, Travis
    Lee, Adam
    Moyse, Davia
    Havers, Fiona P.
    Harding, Lee
    Fry, Alicia M.
    Hall, Aron J.
    Martin, Kelly
    Biel, Marjorie
    Deng, Yangyang
    Meyer, William A., III
    Mathur, Mohit
    Kyle, Tonja
    Gundlapalli, Adi V.
    Thornburg, Natalie J.
    Petersen, Lyle R.
    Edens, Chris
    [J]. JAMA INTERNAL MEDICINE, 2021, 181 (04) : 450 - 460
  • [4] Population-level seropositivity trend for SARS-Cov-2 in Rio Grande do Sul, Brazil
    Barros, Aluisio J. D.
    Victora, Cesar G.
    Menezes, Ana M. B.
    Horta, Bernardo L.
    Barros, Fernando C.
    Hartwig, Fernando P.
    Victora, Gabriel D.
    Vidaletti, Luis Paulo
    Silveira, Mariangela F.
    Mesenburg, Marilia A.
    Jacques, Nadege
    Struchiner, Claudio J.
    Brust, Flavia Roberta
    Dall'Agnol, Marinel M.
    Longaray Delamare, Ana Paula
    Francois, Carlos Henrique R.
    Ikeda, Maria Leticia R.
    Pellegrini, Debora C. P.
    Reuter, Cezane Priscila
    da Silva, Shana G.
    Dellagostin, Odir A.
    Hallal, Pedro C.
    [J]. REVISTA DE SAUDE PUBLICA, 2021, 55
  • [5] Nationally representative SARS-CoV-2 antibody prevalence estimates after the first epidemic wave in Mexico
    Basto-Abreu, Ana
    Carnalla, Martha
    Torres-Ibarra, Leticia
    Romero-Martinez, Martin
    Martinez-Barnetche, Jesus
    Lopez-Martinez, Irma
    Aparicio-Antonio, Rodrigo
    Shamah-Levy, Teresa
    Alpuche-Aranda, Celia
    Rivera, Juan A.
    Barrientos-Gutierrez, Tonatiuh
    [J]. NATURE COMMUNICATIONS, 2022, 13 (01)
  • [6] Global seroprevalence of SARS-CoV-2 antibodies: A systematic review and meta-analysis
    Bobrovitz, Niklas
    Arora, Rahul Krishan
    Cao, Christian
    Boucher, Emily
    Liu, Michael
    Donnici, Claire
    Yanes-Lane, Mercedes
    Whelan, Mairead
    Perlman-Arrow, Sara
    Chen, Judy
    Rahim, Hannah
    Ilincic, Natasha
    Segal, Mitchell
    Duarte, Nathan
    Van Wyk, Jordan
    Yan, Tingting
    Atmaja, Austin
    Rocco, Simona
    Joseph, Abel
    Penny, Lucas
    Clifton, David A.
    Williamson, Tyler
    Yansouni, Cedric P.
    Evans, Timothy Grant
    Chevrier, Jonathan
    Papenburg, Jesse
    Cheng, Matthew P.
    [J]. PLOS ONE, 2021, 16 (06):
  • [7] Seroprevalence of SARS-CoV-2 antibodies in the poorest region of Brazil: results from a population-based study
    de Souza Araujo, Adriano Antunes
    Quintans-Junior, Lucindo Jose
    Heimfarth, Luana
    Schimieguel, Dulce Marta
    Correa, Cristiane Bani
    de Moura, Tatiana Rodrigues
    Cavalcante, Rafael Ciro Marques
    Rodrigues Bomfim, Rangel
    Grespan, Renata
    Santana Rodrigues, Lorranny
    dos Santos, Danillo Menezes
    de Sa Resende, Ayane
    de Lima Silva, Nathanielly
    da Silva Santos, Anna Clara Ramos
    Dantas Araujo, Jessica Maria
    de Souza, Mercia Feitosa
    de Oliveira Goes, Marco Aurelio
    Santana Santos, Victor
    Martins-Filho, Paulo Ricardo
    [J]. EPIDEMIOLOGY AND INFECTION, 2021, 149
  • [8] SARS-CoV-2 genomic surveillance in Northeast Brazil: timing of emergence of the Brazilian variant of concern P1
    dos Santos, Cliomar Alves
    Brito Bezerra, Gabriela Vasconcelos
    Almeida de Azevedo Marinho, Aline Rafaelle Rocha
    Alves, Juliana Cardoso
    Tanajura, Diego Moura
    Martins-Filho, Paulo Ricardo
    [J]. JOURNAL OF TRAVEL MEDICINE, 2021, 28 (07)
  • [9] A systematic review of asymptomatic infections with COVID-19
    Gao, Zhiru
    Xu, Yinghui
    Sun, Chao
    Wang, Xu
    Guo, Ye
    Qiu, Shi
    Ma, Kewei
    [J]. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2021, 54 (01) : 12 - 16
  • [10] Does Density Aggravate the COVID-19 Pandemic? Early Findings and Lessons for Planners
    Hamidi, Shima
    Sabouri, Sadegh
    Ewing, Reid
    [J]. JOURNAL OF THE AMERICAN PLANNING ASSOCIATION, 2020, 86 (04) : 495 - 509